News-Papers
Testimonial
Video Gallery
Melatonin Suppresses the Growth of Ovarian Cancer Cell Lines (OVCAR-429 and PA-1) and Potentiates the Effect of G1 Arrest by Targeting CDKs
Abstract
Melatonin is found in animals as well as plants. In animals, it is a hormone that anticipates the daily onset of darkness and regulates physiological functions, such as sleep timing, blood pressure, and reproduction.
Melatonin has also been found to have anti-tumor properties.
Malignant cancers are the most common cause of death, and the mortality rate of ovarian tumor is the highest among gynecological diseases.
This study investigated the anti-tumor effects of melatonin on the ovarian cancer lines, OVCAR-429 and PA-1.
We observed the accumulation of melatonin-treated cells in the G₁ phase due to the down-regulation of CDK 2 and 4.
Our results suggest that in addition to the known effects on prevention, melatonin may also provide anti-tumor activity in established ovarian cancer.
See also About Melatonin.
Search
Follow us...
Latest
- Expressions of Somatostatin Receptor Subtypes (SSTR-1, 2, 3, 4 and 5) in Neuroblastic Tumors; Special Reference to Clinicopathological Correlations with International Neuroblastoma Pathology Classification and Outcomes
- Characterization of somatostatin receptors on human neuroblastoma tumors
- Somatostatin in neuroblastoma and ganglioneuroma
- Octreotide enhances the sensitivity of the SKOV3/DDP ovarian cancer cell line to cisplatin chemotherapy in vitro
- Inhibition of Human Epithelial Ovarian Cancer Cell Growth in vitro by Somatostatin Analog RC-160
- Melatonin Synergizes the Chemotherapeutic Effect of Cisplatin in Ovarian Cancer Cells Independently of MT1 Melatonin Receptors
- Somatostatin receptor subtype 1 as a potential diagnostic marker and therapeutic target in prostate cancer
- Pretreatment with melatonin protects against cyclophosphamide-induced oxidative stress and renal damage in mice
- Neuropeptide Y- and somatostatin-like immunoreactivities in ganglioneuroma, ganglioneuroblastoma and neuroblastoma
- New signalling pathway involved in the anti-proliferative action of vitamin D₃ and its analogues in human neuroblastoma cells. A role for ceramide kinase
- Neuroblastoma. Correlation of neuropeptide expression in tumor tissue with other prognostic factors
- Melatonin: does it have utility in the treatment of hematologic neoplasms?
Most Read
- All-trans-retinoic acid and cancer
- The Di Bella Method (DBM)
- The Di Bella Method Increases by the 30% the survival rate for Pancreas tumors and for this reason should be proposed as first line therapy for this type of cancer
- Biography
- About melatonin - 1996
- Bibliography
- Non-Hodgkin's Lymphoma, Stage III-B-E: a Case Report
- Somatostatin in oncology, the overlooked evidences
- Chronic Lymphocytic Leukemia: 4 patients, long-lasting remission
- Vademecum
- How effective is chemo therapy?
- Frequently Asked Questions